image
Lantern Pharma Inc. LTRN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.54
1.43 %
$ 38.2 M
Market Cap
-1.99
P/E
BALANCE SHEET
43.6 M ASSETS
-25.82%
Growth Rates
1Year -25.82%
3Years 28.94%
5Years 149.68%
7Years 0.00%
10Years 0.00%
2.74 M LIABILITIES
-2.09%
Growth Rates
1Year -2.09%
3Years 60.65%
5Years 33.27%
7Years 0.00%
10Years 0.00%
40.9 M EQUITY
-27.00%
Growth Rates
1Year -27.00%
3Years 27.58%
5Years 189.89%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Lantern Pharma Inc.
image
Current Assets 43.3 M
Cash & Short-Term Investments 41.3 M
Receivables 0
Other Current Assets 2.04 M
Non-Current Assets 306 K
Long-Term Investments 0
PP&E 280 K
Other Non-Current Assets 25.9 K
Current Liabilities 2.68 M
Accounts Payable 0
Short-Term Debt 173 K
Other Current Liabilities 2.51 M
Non-Current Liabilities 61.5 K
Long-Term Debt 61.5 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 21.9 37.2 51.5 19.2 1.2 0.4
Short Term Investments 19.4 18.0 19.2 0 0 0
Receivables 0 0 0 0 0 0
Inventory 0 (0.6) (0.2) 0 0 0
Other Current Assets 2.0 3.5 1.0 0.8 788 0
Total Current Assets 43.3 58.7 72.7 20.2 1.2 0.4
PP&E 0.3 95.7 K 0.2 21.5 K 8.76 K 4.67 K
Intangible Assets 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 0 0 1.0 0 0 0
Other Long Term Assets 25.9 K 17.9 K 17.9 K 0.1 0.2 0
Other Assets 0 0 0 0 0 0
Total Assets 43.6 58.8 74.0 20.4 1.4 0.4
LIABILITIES
Accounts Payable 0 0.9 0.7 0.4 0.5 97.6 K
Short Term Debt 0.2 52.9 K 0.2 0 0 0
Other Current Liabilities 2.5 1.8 1.5 0.1 11 K 0.6
Total Current Liabilities 2.7 2.8 2.3 0.6 0.5 0.7
Long Term Debt 61.5 K 0 52.9 K 0.1 0 0
Deferred Tax Income 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0
Total Liabilities 2.7 2.8 2.4 0.7 0.5 0.7
EQUITY
Common Stock 1.07 K 1.09 K 1.11 K 622 11.4 K 11.4 K
Retained Earnings (55.2) (39.3) (25.0) (12.7) (6.8) (4.3)
Other Accumulative Comprehensive Income/Loss (0.1) (0.4) 92.7 K 0 0 0
Total Equity 40.9 56.0 71.6 19.7 0.9 (0.2)
Total Liabilities and Equity 43.6 58.8 74.0 20.4 1.4 0.4
SHARES OUTSTANDING
Common Shares Outstanding 10.8 10.9 10.9 6.2 6.3 6.2